Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Rafati

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Plos One|July 22, 2015
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral LeishmaniasisMehdi Shahbazi, Farnaz Zahedifard, Tahereh Taheri, et al.
Frontiers in Cellular and Infection Microbiology|December 6, 2024
Integrated analysis of lncRNA and mRNA expression profiles in cutaneous leishmaniasis lesions caused by <i>Leishmania tropica</i>Shima Hadifar, Nasrin Masoudzadeh, Björn Andersson, et al.
Plos Neglected Tropical Diseases|September 13, 2011
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell responseNegar Seyed, Farnaz Zahedifard, Shima Safaiyan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensisAdnene Salhi, Virmondes Rodrigues, Ferrucio Santoro, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisNoushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, et al.
Diagnostic Microbiology and Infectious Disease|May 19, 2007
The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant womenMajid Golkar, Sima Rafati, Mohamed S Abdel-Latif, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 20, 2019
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasisDiana Caridha, Brian Vesely, Katrien van Bocxlaer, et al.
Scientific Reports|July 2, 2025
Altered miRNA expression in the lesions of cutaneous leishmaniasis caused by L. major and L. tropica with insights into apoptosis regulationTaha Masoudsinaki, Shima Hadifar, Hamzeh Sarvnaz, et al.
Scientific Reports|October 2, 2020
Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropicaNasrin Masoudzadeh, Malin Östensson, Josefine Persson, et al.
Molecular Immunology|July 29, 2022
Blood transcriptional profiles distinguish different clinical stages of cutaneous leishmaniasis in humansFariborz Bahrami, Nasrin Masoudzadeh, Suzanne Van Veen, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Plos One|July 22, 2015
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral LeishmaniasisMehdi Shahbazi, Farnaz Zahedifard, Tahereh Taheri, et al.
Frontiers in Cellular and Infection Microbiology|December 6, 2024
Integrated analysis of lncRNA and mRNA expression profiles in cutaneous leishmaniasis lesions caused by <i>Leishmania tropica</i>Shima Hadifar, Nasrin Masoudzadeh, Björn Andersson, et al.
Plos Neglected Tropical Diseases|September 13, 2011
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell responseNegar Seyed, Farnaz Zahedifard, Shima Safaiyan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensisAdnene Salhi, Virmondes Rodrigues, Ferrucio Santoro, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Development of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisNoushin Saljoughian, Tahereh Taheri, Farnaz Zahedifard, et al.
Diagnostic Microbiology and Infectious Disease|May 19, 2007
The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant womenMajid Golkar, Sima Rafati, Mohamed S Abdel-Latif, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 20, 2019
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasisDiana Caridha, Brian Vesely, Katrien van Bocxlaer, et al.
Scientific Reports|July 2, 2025
Altered miRNA expression in the lesions of cutaneous leishmaniasis caused by L. major and L. tropica with insights into apoptosis regulationTaha Masoudsinaki, Shima Hadifar, Hamzeh Sarvnaz, et al.
Scientific Reports|October 2, 2020
Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropicaNasrin Masoudzadeh, Malin Östensson, Josefine Persson, et al.
Molecular Immunology|July 29, 2022
Blood transcriptional profiles distinguish different clinical stages of cutaneous leishmaniasis in humansFariborz Bahrami, Nasrin Masoudzadeh, Suzanne Van Veen, et al.
Pageof 14